Watson Pharmaceuticals, Inc.

Hikma Pharmaceuticals USA Inc.

Actavis, Inc.

Shahin Fesharaki

Mayank Joshi

Mahmoud Ghannam

Ahmad Arif Mohammad

Mohammad Al Hreebat

Stable and bioavailable oral dosage forms of ibrutinib, the dosage forms comprising ibrutinib and an acidifying agent. The dosage forms can further comprise a binder, such as sodium alginate, a surfactant, a lubricant, a filler and/or a disintegrant. Methods of treating cancers, particularly blood cancers, and graft versus host disease comprising administering to a patient in need thereof a dosage form comprising ibrutinib and an acidifying agent.

Oral dosage forms of ibrutinib

A modified release dosage form for the oral administration of tranexamic acid.

Modified release tranexamic acid formulation

Growing community of inventors

Weston, FL, United States of America

Shahin Fesharaki